New Survey Data Reveals Total Reported Annual Claim Representation for GLP-1 Drugs for Weight Loss Has Increased to Almost Nine Percent A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage surrounding glucagon-like peptide-1 (GLP-1) […]
When it comes to neurodivergence in the workplace, stigma is everywhere. Often, neurotypical people with little outside knowledge or experience have inaccurate assumptions about those with ADHD, autism, dyslexia, down syndrome and other forms of neurodivergence. Additionally, these ways of functioning are […]